Your browser doesn't support javascript.
loading
Prognostic Factors and Long-Term Survival in Locally Advanced NSCLC with Pathological Complete Response after Surgical Resection Following Neoadjuvant Therapy.
Lococo, Filippo; Sassorossi, Carolina; Nachira, Dania; Chiappetta, Marco; Petracca Ciavarella, Leonardo; Vita, Emanuele; Boldrini, Luca; Evangelista, Jessica; Cesario, Alfredo; Bria, Emilio; Margaritora, Stefano.
Afiliação
  • Lococo F; Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Sassorossi C; Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Nachira D; Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Chiappetta M; Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Petracca Ciavarella L; Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Vita E; Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Boldrini L; Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Evangelista J; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.
  • Cesario A; Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.
  • Bria E; Radiotherapy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Margaritora S; Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Cancers (Basel) ; 12(12)2020 Nov 30.
Article em En | MEDLINE | ID: mdl-33265905
ABSTRACT

Background:

Outcomes for locally advanced NSCLC with pathological complete response (pCR), i.e., pT0N0 after induction chemoradiotherapy (IT), have been seldom investigated. Herein, long-term results, in this highly selected group of patients, have been evaluated with the aim to identify prognostic predictive factors.

Methods:

Patients affected by locally advanced NSCLC (cT1-T4/N0-2/M0) who underwent IT, possibly following surgery, from January 1992 to December 2019, were considered for this retrospective analysis. Survival rates and prognostic factors have been studied with Kaplan-Meier analysis, log-rank and Cox regression analysis.

Results:

Three-hundred and forty-three consecutive patients underwent IT in the considered period. Out of them, 279 were addressed to surgery; among them, pCR has been observed in 62 patients (18% of the total and 22% of the operated patients). In the pCR-group, clinical staging was IIb in 3 (5%) patients, IIIa in 28 (45%) patients and IIIb in 31 (50%). Surgery consisted of (bi)lobectomy in the majority of cases (80.7%), followed by pneumonectomy (19.3%). Adjuvant therapy was administered in 33 (53.2%) patients. Five-year overall survival and disease-free survival have been respectively 56.18% and 48.84%. The relative risk of death, observed with the Cox regression analysis, was 4.4 times higher (95% confidence interval (CI) 1.632-11.695, p = 0.03) for patients with N2 multi-station disease, 2.6 times higher (95% CI 1.066-6.407, p = 0.036) for patients treated with pneumonectomy and 3 times higher (95% CI 1.302-6.809, p = 0.01) for patients who did not receive adjuvant therapy.

Conclusions:

Rewarding long-term results could be expected in locally advanced NSCLC patients with pCR after IT followed by surgery. Baseline N2 single-station disease and adjuvant therapy after surgery seem to be associated with better prognosis, while pneumonectomy is associated with poorer outcomes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article